ZYUS Life Sciences Corporation ZYUS.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.20M | -2.23M | -6.98M | -2.63M | -3.20M |
| Total Depreciation and Amortization | 118.50K | 126.10K | 452.60K | 524.90K | 488.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 658.20K | 519.80K | 4.89M | 310.70K | 451.00K |
| Change in Net Operating Assets | 516.60K | 572.20K | 253.90K | -34.90K | 847.80K |
| Cash from Operations | -908.20K | -1.01M | -1.38M | -1.83M | -1.41M |
| Capital Expenditure | -- | -- | -1.40K | -6.50K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 18.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -1.40K | -6.50K | 18.10K |
| Total Debt Issued | 1.08M | 1.43M | 650.00K | 1.65M | 100.00K |
| Total Debt Repaid | -23.00K | -155.00K | -99.00K | -50.00K | -89.00K |
| Issuance of Common Stock | 248.00K | -- | 462.00K | 732.00K | 1.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.00K | -- | 788.00K | -- | -- |
| Cash from Financing | 968.80K | 930.20K | 1.29M | 1.69M | 1.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.70K | -83.80K | -91.80K | -143.80K | -75.20K |